指南与共识重症综合管理与镇静镇痛呼吸衰竭与机械通气

SARS-CoV感染疑似或重症患者的围手术期管理实用建议

Practical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV.
指南 / 共识 · Rev Esp Anestesiol Reanim (Engl Ed) · 2020-03-17
一句话结论SARS-CoV-2无特异性治疗,围手术期管理核心是 adequate 预防措施、支持治疗与并发症处理。

本文为西班牙麻醉与复苏学会发布的围手术期管理实用建议,针对疑似或重症SARS-CoV-2感染患者。文中指出SARS-CoV-2感染临床表现从轻度上呼吸道感染到重度急性呼吸窘迫综合征和脓毒症不等,目前无特异性治疗。根本措施是建立充分的预防措施、支持治疗及并发症管理。原文未报告具体推荐等级、药物剂量或诊断阈值。

要点

  • SARS-CoV-2感染临床表现可从轻度上呼吸道感染到重度急性呼吸窘迫综合征和脓毒症。
  • 目前无SARS-CoV-2特异性治疗,根本措施是充分的预防措施、支持治疗和并发症管理。
  • 围手术期管理应聚焦于预防措施、支持治疗及并发症处理。

适用人群与场景

  • 疑似或重症SARS-CoV-2感染需围手术期管理的患者

处置流程与药物剂量

  • 建立充分的预防措施。
  • 给予支持治疗并管理并发症。

研究设计与关键结果

  • 制定机构:西班牙麻醉与复苏学会(Rev Esp Anestesiol Reanim (Engl Ed))。
  • 方法:实用建议,原文未报告证据分级体系。

证据类型、等级与局限

  • 证据类型:指南/共识(实用建议)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对疑似或重症SARS-CoV-2感染患者,围手术期应建立充分的预防措施并给予支持治疗和并发症管理。

指南或共识出处

  • Rev Esp Anestesiol Reanim (Engl Ed) 发布的SARS-CoV感染疑似或重症患者围手术期管理实用建议

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified as a causative agent of the outbreak a new type of virus of the Coronaviridiae family, called SARS-CoV-2. Since then, thounsands of cases have been reported with global dissemination. Infections in humans cause a broad clinical spectrum ranging from mild upper respiratory tract infection, to severe acute respiratory distress syndrome and sepsis. There is not specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications.

In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified as a causative agent of the outbreak a new type of virus of the Coronaviridiae family, called SARS-CoV-2. Since then, thounsands of cases have been reported with global dissemination. Infections in humans cause a broad clinical spectrum ranging from mild upper respiratory tract infection, to severe acute respiratory distress syndrome and sepsis. There is not specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications.

来源:Rev Esp Anestesiol Reanim (Engl Ed),查看原文。版权归原作者所有。

参考来源

  1. Montero Feijoo A, Maseda E, Adalia Bartolomé R, et al. Practical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV. Rev Esp Anestesiol Reanim (Engl Ed). 2020. PMID: 32197787. doi:10.1016/j.redar.2020.03.003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。